RARA CRAFT DATABASE for FDA Medical Devices
510(k)K182144

FDA DEVICE FACTS

Bi-Flex Evo

Promepla Sam

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATESeptember 7, 2018PRODUCT CODEKNY

Indications for use

The Bi-Flex EVO Ureteral Access Sheath is intended to be a conduit for passage of endoscopes and other urological devices for the purpose of performing ureteroscopy procedures. The dual working lumen dilator with luer lock connections allows the user to insert guidewires and fluids.

F. Technological Characteristics and Performance Data: The changes are modifying the material of the dilator from LDPE to Polyurethane to be able to allow a safer introduction thanks to the increased f lexibility of its tapered tip. In addition, the Bi-Flex Evo has marks printed on the dilator, allowing an easier visualization of penetration depth and thus a safer insertion into patient. In support of this 510(k) premarket notification, Promepla SAM has conducted bench testing to demonstrate that Bi-flex Evo Ur eteral Access Sheath provide adequate mechanical strength for their intended use. All bench testing results confirmed that the products described in this submission met the necessary specification. In addition, the biocompatibility of the devices has been confirmed in accordance with ISO 10993, and the company has conducted sterilization validation in accordance with recognized industry standards. A list of the tests performed to support substantial equivalence is provided below:

- Sterilization Validation;

- Biocompatibility;

- Device verification and validation; The results of these evaluations demonstrate that the Bi-Flex Evo are safe and effective when used in accordance with their intended use and labeling.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 26, 2026